Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 4, Status: Authorised

Guide on access to unpublished documents

Veterinary medicines European public assessment report (EPAR): Quadrisol, vedaprofen, Status: Authorised

Human medicines European public assessment report (EPAR): Okedi, risperidone, Date of authorisation: 14/02/2022, Revision: 4, Status: Authorised

Pool of patient and consumer experts: list for 2024-2029

Pool of healthcare professional experts: list for 2024-2029

Veterinary medicines European public assessment report (EPAR): Respiporc Flu3, inactivated influenza-A virus, Status: Authorised

Veterinary medicines European public assessment report (EPAR): ReproCyc ParvoFLEX, porcine parvovirosis vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Reconcile, fluoxetine, Status: Authorised

Template for scientific document for paediatric investigation plan or product-specific waiver